ESTRO 2024 - Abstract Book

S1558

Clinical - Lower GI

ESTRO 2024

Fig. 1 : Overall survival probability in cohorts with (dotted line) and without (continuous line) pathologic complete response.

Conclusion:

Pathological complete response proved to be a predictive and prognostic factor for OS in patients affected by LARC undergoing NRT. Use of LCCRT was associated with improved rates of pCR, as opposed to cT4 tumors for which treatment intensification might be of interest to increase pCR rates. No difference in terms of pCR was observed according to RSI.

Keywords: pCR, neoadjuvant, rectum

References:

[1] Sauer R, Liersch T, Merkel S, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol. 2012;30(16):1926-1933.

[2] Folkesson J, Birgisson H, Pahlman L, Cedermark B, Glimelius B, Gunnarsson U. Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol. 2005;23(24):5644-5650.

[3] Martin ST, Heneghan HM, Winter DC. Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer. Br J Surg. 2012;99(7):918-928. doi:10.1002/bjs.8702 [4] Maas M, Nelemans PJ, Valentini V, et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol. 2010;11(9):835 844.

[5] Zhang H, Sun G, Zheng K, et al. Prognostic factors in patients with complete response of the tumour (ypT0) after neoadjuvant chemoradiotherapy and radical resection of rectal cancer. ANZ J Surg. 2021;91(4):E190-E195.

[6] Timmerman C, Taveras LR, Huerta S. Clinical and molecular diagnosis of pathologic complete response in rectal cancer: an update. Expert Rev Mol Diagn. 2018;18(10):887-896.

[7] Du D, Su Z, Wang D, Liu W, Wei Z. Optimal Interval to Surgery After Neoadjuvant Chemoradiotherapy in Rectal Cancer: A Systematic Review and Meta-analysis. Clin Colorectal Cancer. 2018;17(1):13-24.